UNI-MB - logo
UMNIK - logo
 
E-resources
Full text
Peer reviewed Open access
  • Mexican consensus on cow's ...
    Alfonso, Ramírez Mayans Jaime; Rubí, Ignorosa Arellano Karen; Manuel, Toro Monjaraz Erick; Roberto, Cervantes Bustamante; Alejandra, Ruiz Castillo Marlene; de Jesús, Medina Vera Isabel; Gabriela, Ayala Germán Ana; Vladimir, Bacarreza Nogales Dante; Lucía, Casas Guzik; Antonio, Chávez Barrera José; Sergio, Díaz Madero; Esther, Flores Fong Laura; Manuel Enrique, Galaz Pantoja Méndez; Ileana, Gris Calvo Judith; Elena, Huerta Hernández Rosa; Elena, Limón Rojas Ana; Héctor, Macías Avilés; Carlos, Méndez Nieto; José Antonio, Ortega Martell; Iván, Oyervides García Carlos; Rubén, Peña Vélez; Nicolás, Reynés Manzur José; Del Mar, Saez de Ocariz Gutiérrez María; Gerardo, Sagols Méndez; Eugenia, Uriquidi Rivera Martha; Liliana, Worona Dibner; Hideo, Wakida Kusunoki Guillermo; Yvan, Vandenplas

    Allergologia et immunopathologia, 2024, Volume: 52, Issue: 1
    Journal Article

    The aim of this study is to present the current views of a diverse group of experts on the diagnosis and treatment of Cow's Milk Protein Allergy (CMPA) in children under 2 years of age in Mexico. The study, led by a scientific committee of five experts in CMPA, was divided into six phases, including a modified Delphi process. A total of 20 panelists, all of whom were pediatric specialists, participated in administering a comprehensive 38-item questionnaire. The questionnaire was divided into two blocks: Diagnosis and Treatment (20 items each). Consensus was reached on all the proposed items, with an agreement rate of over 70% for each of them. As a result, a diagnostic and treatment algorithm was developed that emphasized the reduction of unnecessary diagnostic studies and encouraged breastfeeding whenever possible. In cases where breast milk is not available, appropriate use of hypoallergenic formulas was recommended. In addition, recommendations on treatment duration and gradual reintroduction of cow's milk protein were provided. The recommendations endorsed by 20 Mexican pediatricians through this study are applicable to everyday clinical practice, thereby enhancing the diagnosis and treatment of children under 2 years of age with CMPA. This, in turn, will foster improved health outcomes and optimize the utilization of healthcare resources.